In addition, knockdown of MDM2 results in a reduction of MMP2 gene expression and increase in MMP3, MMP10 and MMP13 gene expression and decreased growth and migration of breast cancer cells, and the mechanism may involve the interplay between MDM2 and prostate-specific membrane antigen (PSMA) [65]. The gene discussed is FOLH1; the disease is breast carcinoma.